Purchase this article with an account.
Steffen Schmitz-Valckenberg, Christian K. Brinkmann, Florian Alten, Philipp Herrmann, Nina K. Stratmann, Arno P. Göbel, Monika Fleckenstein, Martin Diller, Glenn J. Jaffe, Frank G. Holz; Semiautomated Image Processing Method for Identification and Quantification of Geographic Atrophy in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2011;52(10):7640-7646. doi: 10.1167/iovs.11-7457.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To determine intraobserver and interobserver longitudinal measurement variability of novel semiautomated software for quantification of age-related macular degeneration-associated geographic atrophy (GA) based on confocal scanning laser ophthalmoscopy fundus autofluorescence (FAF) imaging.
Three-field FAF (excitation 488 nm, emission 500–700 nm), near-infrared reflectance (820 nm), and blue reflectance (488 nm) images of 30 GA subjects were recorded according to a standardized protocol at baseline after 6 and 12 months. At all visits, the GA area was analyzed on central FAF images by seven independent readers using semiautomated software. The software allows direct export of FAF images from the database and semiautomated detection of atrophic areas by shadow correction, vessel detection, and selection of seed points.
The mean size of atrophy at baseline and the mean progression rate were 5.96 mm2 (range, 1.80–15.87) and 1.25 mm2/year (0.42–2.93), respectively. Mean difference of interobserver agreement (Bland-Altman statistics) ranged from −0.25 to 0.30 mm2 for the baseline visit and from −0.14 to 0.11 mm2/year for the atrophy progression rate. Corresponding reflectance images were helpful for lesion boundary discrimination, particularly for evaluation of foveal GA involvement and when image quality was poor.
The new image processing software offers an accurate, reproducible, and time-efficient identification and quantification of outer retinal atrophy and its progression over time. It facilitates measurements both in natural history studies and in interventional trials to evaluate new pharmacologic agents designed to limit GA enlargement.
This PDF is available to Subscribers Only